For most people, paroxysmal supraventricular tachycardia (PSVT) is not dangerous. Episodes can be frightening, with heart rates that spike well above 100 beats per minute, but the condition rarely causes lasting harm in otherwise healthy individuals. That said, PSVT does carry real risks in certain situations, and frequent episodes left untreated can eventually affect heart function.
What Happens During an Episode
During a PSVT episode, an electrical short circuit in the upper chambers of the heart causes it to beat abnormally fast. Heart rates typically range from 150 to 250 beats per minute. Episodes start and stop abruptly, often lasting seconds to minutes, though some can persist for hours. Most people feel a sudden pounding or fluttering in the chest, sometimes accompanied by lightheadedness, shortness of breath, or a sense of anxiety.
In a healthy heart, even a prolonged episode is unlikely to cause structural damage. The heart is beating fast, but it’s still coordinating its contractions effectively. This is the key distinction between PSVT and more dangerous rhythms like ventricular tachycardia, which originates in the lower chambers and can quickly become life-threatening.
When PSVT Becomes Dangerous
The risk profile changes significantly when PSVT occurs alongside other heart conditions. People with coronary artery disease can develop reduced blood flow to the heart muscle during a fast episode, potentially triggering a heart attack. Those with existing heart failure may tip into acute decompensation, where the heart can no longer pump effectively. Elderly patients are particularly vulnerable to these complications.
Symptoms that signal a more serious episode include chest pain, fainting or near-fainting, severe shortness of breath, and a drop in blood pressure. These indicate the heart isn’t keeping up with the body’s demands and require emergency treatment, which may include electrical cardioversion to reset the rhythm.
A rare but notable exception involves Wolff-Parkinson-White (WPW) syndrome, a condition where an extra electrical pathway connects the upper and lower heart chambers. PSVT in people with WPW carries a higher risk of cardiac arrest or sudden death, particularly in athletes and people with physically demanding occupations. This is one reason doctors sometimes recommend further testing after a first PSVT episode.
Long-Term Risks of Frequent Episodes
One underappreciated risk is what happens when PSVT episodes are frequent or prolonged over months or years. The heart muscle can weaken from being overworked, a condition called tachycardia-induced cardiomyopathy. Any sustained heart rate above 100 beats per minute, if it occurs often enough or lasts long enough, can contribute to this. The heart chambers enlarge and lose pumping efficiency, eventually producing symptoms of heart failure like fatigue, swelling, and breathlessness.
The good news is that this form of heart weakening is largely reversible once the abnormal rhythm is controlled. But it reinforces why people with frequent PSVT episodes benefit from treatment rather than simply tolerating them.
Mortality Statistics in Context
A study using the CDC WONDER database found roughly 31,000 SVT-related deaths in the United States between 1999 and 2020, with an age-adjusted mortality rate of about 0.6 per 100,000 people. That rate is low, but it’s not zero. Death rates climb steeply with age, reaching 9.1 per 100,000 in people 85 and older. Rural populations also showed slightly higher mortality than urban ones (1.0 versus 0.6 per 100,000), possibly reflecting differences in access to emergency care. These numbers include all types of supraventricular tachycardia, not just PSVT specifically, but they challenge the assumption that the condition is entirely harmless.
Common Triggers
PSVT episodes don’t usually happen randomly. The most commonly reported triggers include alcohol, caffeine, physical exertion, and sleep deprivation. Caffeine promotes the release of stress hormones and affects calcium signaling within heart cells, both of which can make the heart’s electrical system more excitable. Nicotine, dehydration, and emotional stress are also well-recognized triggers. Identifying and managing your personal triggers can meaningfully reduce how often episodes occur, though it won’t prevent them entirely.
Stopping an Episode at Home
Many people can terminate a PSVT episode on their own using vagal maneuvers. These are physical techniques that stimulate the vagus nerve and slow electrical conduction through the heart. The most common approach is the Valsalva maneuver: bearing down as if straining during a bowel movement, holding for 10 to 15 seconds, then releasing. A modified version, where you lie flat and raise your legs immediately after straining, has shown success rates above 40%, roughly double that of the standard technique. Overall, vagal maneuvers convert PSVT back to a normal rhythm 20 to 40% of the time.
If vagal maneuvers don’t work and the episode continues, a hospital visit may be needed. A short-acting medication given through an IV stops the arrhythmia in about 93% of cases. It works within seconds and clears the body almost as quickly, though it briefly causes an uncomfortable sensation of chest pressure and flushing.
Permanent Treatment Options
For people who want to eliminate PSVT rather than manage it episode by episode, catheter ablation is the standard cure. A thin wire is threaded through a blood vessel to the heart, where targeted energy destroys the small area of tissue responsible for the short circuit. The procedure successfully eliminates the target rhythm in about 96% of patients. Among those with a successful procedure, roughly 7% experience a recurrence, and a second procedure can usually address it.
Recurrence rates vary depending on the specific type of circuit involved. The most common form of PSVT, called AVNRT, has the lowest recurrence rate at about 6%. Accessory pathways in certain locations, particularly near the front of the heart’s septum, recur more often. Your electrophysiologist can give you a more precise estimate based on the specific findings during your procedure.
Daily medications to prevent episodes are another option, typically reserved for people who prefer not to have a procedure or who have infrequent, well-tolerated episodes. These reduce the frequency and severity of episodes but don’t cure the underlying electrical abnormality.